Global Brachytherapy Market

Brachytherapy Market Size, Share, Growth Analysis, By Technique(High Dose Rate (HDR), Low Dose Rate (LDR)), By Application(Gynecological Cancer, Prostate Cancer, Breast Cancer, Others), By End User(Hospitals, Specialty Clinics, Others), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35D2138 | Region: Global | Published Date: April, 2024
Pages: 219 | Tables: 90 | Figures: 78

Brachytherapy Market Competitive Landscape

The global brachytherapy market is highly competitive, with several key players competing for market share. These companies focus on developing advanced brachytherapy technologies, expanding their product portfolios, and expanding their presence in emerging markets.

Brachytherapy Market Top Player’s Company Profiles

  • IsoAid LLC (United States)
  • Theragenics Corporation (United States)
  • C. R. Bard, Inc. (United States)
  • Boston Scientific Corporation (United States)
  • Isoray Inc. (United States)
  • Nucletron B.V. (Netherlands)
  • Huiheng Medical, Inc. (China)
  • iCAD, Inc. (United States)
  • Elekta AB (Sweden)
  • Nanobiotix SA (France)
  • BTG International Ltd. (United Kingdom)
  • GE Healthcare (United States)
  • IBA Worldwide (Belgium)
  • Cianna Medical, Inc. (United States)
  • Theragenics Corporation (United States)
  • C4 Imaging LLC (United States)
  • CIVCO Medical Solutions (United States)
  • RaySearch Laboratories AB (Sweden)
  • Hologic, Inc. (United States)

Brachytherapy Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Brachytherapy Market size was valued at USD 500.1 Million in 2022 and is poised to grow from USD 539.61 Million in 2023 to USD 991.4 Million by 2031, at a CAGR of 7.9% during the forecast period (2024-2031).

The global brachytherapy market is highly competitive, with several key players competing for market share. These companies focus on developing advanced brachytherapy technologies, expanding their product portfolios, and expanding their presence in emerging markets. 'Eckert & Ziegler BEBIG (Germany)', 'Varian Medical Systems, Inc. (United States)', 'Elekta AB (Sweden)', 'IsoAid LLC (United States)', 'Theragenics Corporation (United States)', 'C. R. Bard, Inc. (United States)', 'Boston Scientific Corporation (United States)', 'Isoray Inc. (United States)', 'Nucletron B.V. (Netherlands)', 'Huiheng Medical, Inc. (China)', 'iCAD, Inc. (United States)', 'Elekta AB (Sweden)', 'Nanobiotix SA (France)', 'BTG International Ltd. (United Kingdom)', 'GE Healthcare (United States)', 'IBA Worldwide (Belgium)', 'Cianna Medical, Inc. (United States)', 'Theragenics Corporation (United States)', 'C4 Imaging LLC (United States)', 'CIVCO Medical Solutions (United States)', 'RaySearch Laboratories AB (Sweden)', 'Hologic, Inc. (United States)'

Minimally invasive treatment procedures are preferred by patients due to reduced post-operative complications, shorter hospital stays, and faster recovery times. Brachytherapy is a minimally invasive treatment option that can be performed on an outpatient basis in many cases. The increasing demand for minimally invasive procedures contributes to the growth of the brachytherapy market.

Growing preference for organ-preserving treatments : Brachytherapy is often chosen as an organ-preserving treatment modality, particularly in cancers such as prostate, breast, and cervical cancer. It allows for targeted radiation delivery while minimizing damage to surrounding healthy tissues, thereby preserving organ function and improving quality of life for patients. The trend towards organ preservation and minimally invasive treatments has led to increased adoption of brachytherapy.

With a 45.7% revenue share in 2023, North America dominated the brachytherapy market. Due to the benefits, it provides over conventional methods—namely, that it is a relatively safer and effective cancer treatment—brachytherapy is commonly utilized in North America. In 2022, Europe represented a share of almost 25,0%. Over the past five years, brachytherapy use in the European region has grown.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Brachytherapy Devices Market
Buy Now GET FREE SAMPLE
Radiotherapy Market
Buy Now GET FREE SAMPLE
Electrotherapy Market
Buy Now GET FREE SAMPLE
Aromatherapy Market
Buy Now GET FREE SAMPLE
Prostate Cancer Treatment Market
Buy Now GET FREE SAMPLE
Practice Therapy Market
Buy Now GET FREE SAMPLE
Cell Therapy Market
Buy Now GET FREE SAMPLE
Male Breast Cancer Treatment Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Brachytherapy Market

Report ID: SQMIG35D2138

$5,300
BUY NOW GET FREE SAMPLE